Lamiter

Terbinafine, the active ingredient in Lamiter, is an allylamine antifungal presented as a topical formulation for skin use. It treats dermatophyte skin infections such as tinea corporis, tinea pedis, and tinea cruris in adults and children.

GNH USA supplies Lamiter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamiter, an allylamine antifungal, is indicated for dermatophyte infections of the skin.

- Tinea corporis: reduces fungal growth and clears ring‑shaped lesions on the body. - Tinea pedis: alleviates itching and scaling on the feet by eradicating the causative fungus. - Tinea cruris: treats fungal infection of the groin area, improving redness and discomfort.

Lamiter may cause local and systemic reactions.

Common Side Effects: - Burning sensation at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or scaling of the skin. - Stinging or tingling. - Mild irritation.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Severe skin rash or urticaria. - Angioedema. - Stevens‑Johnson syndrome (very rare). - Hepatic enzyme elevation with systemic absorption. - Anaphylactic reaction.

Before using Lamiter, consider the following precautions.

- Application area: apply to clean, dry skin as directed. - Age restrictions: safety not established in children under 2 years. - Pregnancy: consult a healthcare professional; data are limited. - Concurrent topical agents: avoid overlapping use with other antifungal or irritant products. - Allergy: discontinue use if signs of hypersensitivity appear. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Lamiter may interact with other substances.

Major Interactions (Avoid): - Oral terbinafine: concurrent use can increase systemic exposure. - Strong CYP450 inhibitors: may raise terbinafine levels. - Other topical irritants: can exacerbate skin irritation.

Moderate Interactions (Monitor Closely): - Alcohol‑based skin products: may increase dryness. - Topical corticosteroids: may reduce antifungal efficacy. - Phototoxic agents: monitor for increased photosensitivity.